# Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

> **NCT04153760** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Calgary** · enrollment: 257 (actual)

## Conditions studied

- Venous Thromboembolism
- Postpartum Period
- Aspirin

## Interventions

- **DRUG:** Aspirin 81 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04153760
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-07
- **Primary completion:** 2023-09-05
- **Final completion:** 2023-09-05
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04153760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04153760, "Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04153760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*